Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7953850, 14 pages
https://doi.org/10.1155/2017/7953850
Research Article

Polydatin Protects Rat Liver against Ethanol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-B p65 Pathway

1Guangdong Provincial Key Laboratory of New Chinese Medicinal Development and Research, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
2The First Affiliated Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, 12 Airport Road, Baiyun District, Guangzhou 510405, China
3Dongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Dongguan 523808, China
4Higher Education Institute and Development Research of Chinese Medicine, 12 Airport Road, Baiyun District, Guangzhou 510405, China

Correspondence should be addressed to Jian-Nan Chen; nc.ude.mcuzg@nannaijnehc and You-Liang Xie; moc.621@321gnailuoyeix

Received 5 August 2017; Revised 11 October 2017; Accepted 17 October 2017; Published 8 November 2017

Academic Editor: Raffaele Capasso

Copyright © 2017 Qiong-Hui Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Bai, Y. Yang, Y.-L. Yao et al., “Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway,” Pharmacological Research, vol. 105, pp. 1–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Yang, C. Dong, and G. Ren, “Effect of soyasaponins-rich extract from soybean on acute alcohol-induced hepatotoxicity in mice,” Journal of Agricultural and Food Chemistry, vol. 59, no. 4, pp. 1138–1144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Wang, X.-J. Zhang, F. Liu et al., “Saponins isolated from the leaves of Panax notoginseng protect against alcoholic liver injury via inhibiting ethanol-induced oxidative stress and gut-derived endotoxin-mediated inflammation,” Journal of Functional Foods, vol. 19, pp. 214–224, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Yamashita, M. Goto, I. Matsui-Yuasa, and A. Kojima-Yuasa, “Ecklonia cava polyphenol has a protective effect against ethanol-induced liver injury in a cyclic AMP-dependent manner,” Marine Drugs, vol. 13, no. 6, pp. 3877–3891, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-W. Cao, Y. Jiang, D.-Y. Zhang et al., “Protective effects of Penthorum chinense Pursh against chronic ethanol-induced liver injury in mice,” Journal of Ethnopharmacology, vol. 161, pp. 92–98, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions - Journal, vol. 160, no. 1, pp. 1–40, 2006. View at Google Scholar
  7. A. D. Sarma, A. R. Mallick, and A. K. Ghosh, “Free Radicals and Their Role in Different Clinical Conditions: An Overview,” International Journal of Pharma Sciences & Research, vol. 1, no. 3, 2010. View at Google Scholar
  8. C. Lu, W. Xu, F. Zhang et al., “Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress,” International Immunopharmacology, vol. 29, no. 2, pp. 613–621, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Fernández-Checa et al., “Oxidative stress and alcoholic liver disease,” Alcohol Health & Research World, vol. 21, no. 4, pp. 321–324, 1997. View at Google Scholar
  10. A.-J. Tien, C.-Y. Chien, Y.-H. Chen, L.-C. Lin, and C.-T. Chien, “Fruiting Bodies of Antrodia cinnamomea and Its Active Triterpenoid, Antcin K, Ameliorates N-Nitrosodiethylamine-Induced Hepatic Inflammation, Fibrosis and Carcinogenesis in Rats,” American Journal of Chinese Medicine, vol. 45, no. 1, pp. 173–198, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-Y. Chang, Y.-C. Liu, Y.-H. Kuo et al., “Effects of antrosterol from Antrodia camphorata submerged whole broth on lipid homeostasis, antioxidation, alcohol clearance, and anti-inflammation in livers of chronic-alcohol fed mice,” Journal of Ethnopharmacology, vol. 202, pp. 200–207, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Zeng, C.-L. Zhang, F.-Y. Song et al., “The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 10, pp. 4848–4859, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-W. Wang, X.-Y. Chen, P.-Y. Hu et al., “Effects of linderae radix extracts on a rat model of alcoholic liver injury,” Experimental and Therapeutic Medicine, vol. 11, no. 6, pp. 2185–2192, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. D. H. Lee, D. H. Kim, C. J. Hwang et al., “Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses,” Clinical Science, vol. 128, no. 10, pp. 695–706, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Zhang, C.-H. Yu, Y.-P. Jiang et al., “Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice,” PLoS ONE, vol. 7, no. 9, Article ID e46574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Du, L.-N. Sun, W.-W. Xing et al., “Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters,” Phytomedicine, vol. 16, no. 6-7, pp. 652–658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zeng, Z. Chen, T. Li, and et al, “Polydatin: a new therapeutic agent against multiorgan dysfunction,” Journal of Surgical Research, vol. 198, no. 1, pp. 192–199, 2015. View at Publisher · View at Google Scholar
  18. L. Q. Xu et al., “Polydatin attenuates D-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice,” Food & Function.
  19. M. Koneru, B. D. Sahu, S. Gudem et al., “Polydatin alleviates alcohol-induced acute liver injury in mice: Relevance of matrix metalloproteinases (MMPs) and hepatic antioxidants,” Phytomedicine, vol. 27, pp. 23–32, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kasdallah-Grissa, B. Mornagui, E. Aouani et al., “Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver,” Life Sciences, vol. 80, no. 11, pp. 1033–1039, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Zhang, C.-H. Yu, Y.-P. Jiang et al., “Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice,” PLoS ONE, vol. 7, no. 9, Article ID e46574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L.-Y. Chen, Q. Chen, X.-J. Zhu et al., “Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism,” International Immunopharmacology, vol. 36, pp. 23–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Kim, D.-S. Oh, J. Y. Oh, T. G. Son, D. Y. Yuk, and Y.-S. Jung, “Silymarin Prevents Restraint Stress-Induced Acute Liver Injury by Ameliorating Oxidative Stress and Reducing Inflammatory Response,” Molecules, vol. 21, no. 4, article no. 443, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. M.-S. Kim, M. Ong, and X. Qu, “Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?” World Journal of Gastroenterology, vol. 22, no. 1, pp. 8–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Goldberg and C. Watts, “Serum enzyme changes as evidence of liver reaction to oral alcohol.,” Gastroenterology, vol. 49, no. 3, pp. 256–261, 1965. View at Google Scholar · View at Scopus
  26. Y.-L. Hsieh, Y.-H. Yeh, Y.-T. Lee, and C.-Y. Huang, “Protective effects of Cholestin on ethanol induced oxidative stress in rats,” Journal of the Science of Food and Agriculture, vol. 95, no. 4, pp. 799–808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chakroun, L. Ezzi, I. Grissa et al., “Hematological, biochemical, and toxicopathic effects of subchronic acetamiprid toxicity in Wistar rats,” Environmental Science and Pollution Research, vol. 23, no. 24, pp. 25191–25199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Guo, Z. Shen, H. Yu et al., “Carnosic acid protects against acetaminophen-induced hepatotoxicity by potentiating Nrf2-mediated antioxidant capacity in mice,” Korean Journal of Physiology & Pharmacology, vol. 20, no. 1, pp. 15–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Bati, I. Celik, and A. Dogan, “Determination of Hepatoprotective and Antioxidant Role of Walnuts Against Ethanol-Induced Oxidative Stress in Rats,” Cell Biochemistry and Biophysics, vol. 71, no. 2, pp. 1191–1198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Bertola, O. Park, and B. Gao, “Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin,” Hepatology, vol. 58, no. 5, pp. 1814–1823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Xu, H. Huang, Z. Zhang, and F.-S. Wang, “The role of neutrophils in the development of liver diseases,” Cellular & Molecular Immunology, vol. 11, no. 3, pp. 224–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. G. Meadows and H. Zhang, “Effects of alcohol on tumor growth, metastasis, immune response, and host survival,” Alcohol Research: Current Reviews, vol. 37, no. 2, 2015. View at Google Scholar · View at Scopus
  33. C.-Y. Bang, J.-H. Byun, H.-K. Choi, J.-S. Choi, and S.-Y. Choung, “Protective effects of Ecklonia stolonifera extract on ethanol-induced fatty liver in rats,” Biomolecules & Therapeutics, vol. 24, no. 6, pp. 650–658, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Zhang, Y. Tan, F. Yao, and Q. Zhang, “Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c,” Molecular Medicine Reports, vol. 6, no. 4, pp. 815–820, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Wu and A. Cederbaum, “Oxidative stress and alcoholic liver disease,” Seminars in Liver Disease, vol. 29, no. 2, pp. 141–154, 2009. View at Publisher · View at Google Scholar
  36. M. Adachi and H. Ishii, “Role of mitochondria in alcoholic liver injury,” Free Radical Biology & Medicine, vol. 32, no. 6, pp. 487–491, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Bailey and C. C. Cunningham, “Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes,” Hepatology, vol. 28, no. 5, pp. 1318–1326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. D.-C. Wen, X.-Y. Hu, Y.-Y. Wang et al., “Effects of aqueous extracts from Panax ginseng and Hippophae rhamnoides on acute alcohol intoxication: An experimental study using mouse model,” Journal of Ethnopharmacology, vol. 192, pp. 67–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Albano, “Alcohol, oxidative stress and free radical damage,” Proceedings of the Nutrition Society, vol. 65, no. 3, pp. 278–290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Guo and J. Ren, “Alcohol and acetaldehyde in public health: from marvel to menace,” International Journal of Environmental Research and Public Health, vol. 7, no. 4, pp. 1285–1301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Seki, T. Kitada, H. Sakaguchi, K. Nakatani, and K. Wakasa, “Pathological significance of oxidative cellular damage in human alcoholic liver disease,” Histopathology, vol. 42, no. 4, pp. 365–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. L. Smathers, J. J. Galligan, B. J. Stewart, and D. R. Petersen, “Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease,” Chemico-Biological Interactions, vol. 192, no. 1-2, pp. 107–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Zhu, Z. Jia, H. Misra, and Y. R. Li, “Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence,” Journal of Digestive Diseases, vol. 13, no. 3, pp. 133–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. M. D. Wheeler, H. Kono, M. Yin et al., “Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats,” Gastroenterology, vol. 120, no. 5, pp. 1241–1250, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Bataille and J. E. Manautou, “Nrf2 a potential target for new therapeutics in liver disease,” Clinical Pharmacology & Therapeutics, vol. 92, no. 3, pp. 340–348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. He, Y. Wu, J. Shun, Y. Liang, M. Cheng, and Y. Wang, “Baicalin Ameliorates Liver Injury Induced by Chronic plus Binge Ethanol Feeding by Modulating Oxidative Stress and Inflammation via CYP2E1 and NRF2 in Mice,” Oxidative Medicine and Cellular Longevity, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  47. R. Zhou, J. J. Lin, and D. F. Wu, “Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 1, pp. 209–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. A. I. Cederbaum, “Nrf2 and antioxidant defense against CYP2E1 toxicity.,” Subcellular Biochemistry, vol. 67, pp. 105–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Lu, X. H. Zhang, and A. I. Cederbaum, “Ethanol induction of CYP2A5: Role of CYP2E1-ROS-Nrf2 pathway,” Toxicological Sciences, vol. 128, no. 2, pp. 427–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. P. E. Gong and A. I. Cederbaum, “Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1,” Hepatology, vol. 43, no. 1, pp. 144–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Jaeschke, “Reactive oxygen and mechanisms of inflammatory liver injury,” Journal of Gastroenterology and Hepatology, vol. 15, no. 7, pp. 718–724, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Du, C. D. Williams, M. R. McGill et al., “The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation,” Toxicology and Applied Pharmacology, vol. 273, no. 3, pp. 484–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. R.-B. Ding, K. Tian, L.-L. Huang et al., “Herbal medicines for the prevention of alcoholic liver disease: a review,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 457–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. P. C. Benias, K. Gopal, H. Bodenheimer, and N. D. Theise, “Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C,” Clinics and Research in Hepatology and Gastroenterology, vol. 36, no. 5, pp. 448–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Iimuro and J. Fujimoto, “TLRs, NF-κB, JNK, and liver regeneration,” Gastroenterology Research and Practice, Article ID 598109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Djafarzadeh, M. Vuda, J. Takala, M. Ochs, and S. M. Jakob, “Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes,” Mitochondrion, vol. 11, no. 1, pp. 83–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. J. W. Wang, “Effects of Linderae radix extracts on a rat model of alcoholic liver injury,” Experimental & Therapeutic Medicine, vol. 11, no. 6, pp. 2185–2192, 2016. View at Publisher · View at Google Scholar
  58. S. Ramm and A. Mally, “Erratum to Role of drug-independent stress factors in liver injury associated with diclofenac intake,” Toxicology, vol. 316, no. 1, pp. 71–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Shen, L. Yang, S. Yan et al., “Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity,” Molecular and Cellular Endocrinology, vol. 412, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Wang, S. Song, Y. Zhang et al., “Inhibition of the Rho/Rho kinase pathway prevents lipopolysaccharide-induced hyperalgesia and the release of TNF-α and IL-1β in the mouse spinal cord,” Scientific Reports, vol. 5, Article ID 14553, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Q. Xu, Y. L. Xie, S. H. Gui, X. Xie, and Z. Z. Mo, “Polydatin attenuates D-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice,” Food & Function, vol. 7, no. 11, pp. 4545–4555, 2016. View at Google Scholar
  62. B. Bellaver, L. D. Bobermin, D. G. Souza et al., “Signaling mechanisms underlying the glioprotective effects of resveratrol against mitochondrial dysfunction,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1862, no. 9, pp. 1827–1838, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. K. S. Bhullar and B. P. Hubbard, “Lifespan and healthspan extension by resveratrol,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1852, no. 6, pp. 1209–1218, 2015. View at Publisher · View at Google Scholar
  64. N. Lanthier and P. Stärkel, “Treatment of severe alcoholic hepatitis: past, present and future,” European Journal of Clinical Investigation, vol. 47, no. 7, pp. 531–539, 2017. View at Publisher · View at Google Scholar
  65. S. M. Yeligar, K. Machida, and V. K. Kalra, “Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1α and Nrf2 to attenuate inflammatory cytokine expression,” The Journal of Biological Chemistry, vol. 285, no. 46, pp. 35359–35373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Lin, W. Chuang, F. Lu, and C. Chen, “Anti-oxidant and anti-inflammatory effects of hydrogen-rich water alleviate ethanol-induced fatty liver in mice,” World Journal of Gastroenterology, vol. 23, no. 27, p. 4920, 2017. View at Publisher · View at Google Scholar
  67. A. Louvet and P. Mathurin, “Alcoholic liver disease: mechanisms of injury and targeted treatment,” Nature Reviews Gastroenterology & Hepatology, vol. 12, no. 4, pp. 231–242, 2015. View at Publisher · View at Google Scholar
  68. Y. Liu, J. Wang, L. Li et al., “Hepatoprotective Effects of Antrodia cinnamomea: The Modulation of Oxidative Stress Signaling in a Mouse Model of Alcohol-Induced Acute Liver Injury,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 7841823, 2017. View at Publisher · View at Google Scholar · View at Scopus
  69. P. A. Baeuerle and T. Henkel, “Function and activation of NF-κB in the immune system,” Annual Review of Immunology, vol. 12, pp. 141–179, 1994. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Frankenberger, A. Pforte, T. Sternsdorf, B. Passlick, P. A. Baeuerle, and H. W. L. Ziegler-Heitbrock, “Constitutive nuclear NF-κB in cells of the monocyte lineage,” Biochemical Journal, vol. 304, no. 1, pp. 87–94, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. M. B. Toledano and W. J. Leonard, “Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 88, no. 10, pp. 4328–4332, 1991. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Kamata and H. Hirata, “Redox regulation of cellular signalling,” Cellular Signalling, vol. 11, no. 1, pp. 1–14, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Asehnoune, D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham, “Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B,” The Journal of Immunology, vol. 172, no. 4, pp. 2522–2529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Abraham, “Nuclear factor-kappa B and its role in sepsis-associated organ failure,” The Journal of Infectious Diseases, vol. 187, pp. S364–S369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Flohé, R. Brigelius-Flohé, C. Saliou, M. G. Traber, and L. Packer, “Redox regulation of NF-kappa B activation,” Free Radical Biology & Medicine, vol. 22, no. 6, pp. 1115–1126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. M. Janssen-Heininger, M. E. Poynter, and P. A. Baeuerle, “Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappa B,” Free Radical Biology & Medicine, vol. 28, no. 9, pp. 1317–1327, 2000. View at Publisher · View at Google Scholar · View at Scopus